Matej Mikulic
Research expert covering health, pharma & medtech
AbbVie - Statistics & Facts
AbbVie has established itself as one of the world鈥檚 leading biopharmaceutical companies, with prescription drug sales exceeding 54 billion U.S. dollars in 2024, placing it among the industry鈥檚 top players. By 2025, total company revenue reached roughly 61 billion U.S. dollars. The company鈥檚 strength lies in its focus on high-value therapeutic areas, particularly immunology, where AbbVie remains the global leader with segment revenues exceeding 25 billion U.S. dollars. This specialization has enabled AbbVie to build a strong market position despite intense competition from other global pharmaceutical giants.聽
